SPHS
Sophiris Bio, Inc.
SPHS
SPHS
Delisted
SPHS was delisted on the 11th of March, 2020.
31 hedge funds and large institutions have $2.15M invested in Sophiris Bio, Inc. in 2018 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less first-time investments, than exits
New positions opened: | Existing positions closed:
68% less capital invested
Capital invested by funds: $6.73M → $2.15M (-$4.58M)
Holders
31
Holding in Top 10
–
Calls
$21K
Puts
$28K
Top Buyers
| 1 | +$52K | |
| 2 | +$36.8K | |
| 3 | +$30K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$26.2K |
| 5 |
HP
Hikari Power
Tokyo,
Japan
|
+$25.7K |
Top Sellers
| 1 | -$123K | |
| 2 | -$66K | |
| 3 | -$32K | |
| 4 |
IP
Intellectus Partners
San Francisco,
California
|
-$24K |
| 5 |
Bank of New York Mellon
New York
|
-$8.28K |